DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)



company name or ticker

Could These 3 Biotechs Help Fight the MERS Virus?

Inovio Pharmaceuticals, Novavax, and Nanoviricides are developing treatments for the deadly MERS virus. Here’s what you need to know.

Novavax: A Unique Opportunity

Here's What You Need to Know About Inovio Pharmaceuticals' First-Quarter Earnings

A Foolish take on Inovio's first-quarter earnings report.

One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained

One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels of Immune Response

Key Takeaways From Novavax's First-Quarter Earnings

Here's what you need to know about Novavax's first-quarter earnings report.

Novavax's (NVAX) CEO Stanley Erck on Q1 2014 Results - Earnings Call Transcript

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

Novavax's VP of R&D Says Production of MERS Vaccine is Analagous to Situation Described in NEJM Pape

Novavax's VP of R&D Says Production of MERS Vaccine is Analagous to Situation Described in NEJM Paper on H7n9

Why XOMA, Zillow, and Novavax Are Today's 3 Best Stocks

Strong earnings reports help push the S&P 500 higher for the ninth time in 11 sessions, as XOMA, Zillow, and Novavax lead all stocks to the upside.

Why Novavax Inc. Shares Took Flight

Positive top-line results from a midstage RSV vaccine study send Novavax shares higher, but here's what investors should really be focused on.
See More Articles...